y Subsequent renewal certificates where applicable or a copy certified by an Attorney at law, of aforesaid document

KazakhTenders notice for y Subsequent renewal certificates where applicable or a copy certified by an Attorney at law, of aforesaid document. The reference ID of the tender is 109155679 and it is closing on 26 Nov 2024.

100% Secure Payments

Tender Details

  • Country: Sri Lanka
  • Summary: y Subsequent renewal certificates where applicable or a copy certified by an Attorney at law, of aforesaid document
  • KZT Ref No: 109155679
  • Deadline: 26 Nov 2024
  • Competition: ICB
  • Financier: Self Financed
  • Purchaser Ownership: Public
  • Tender Value: Refer Document
  • Notice Type: Tender
  • Document Ref. No.: DHS/SA/WW/115/22
  • Purchaser's Detail :
  • Purchaser : STATE PHARMACEUTICALS CORPORATION OF SRI LANKA
    No.75, Sir Baron Jayathilake Mawatha, Colombo 01, Sri Lanka. Telephone :+94 (0)11 2320356-9, Fax :+94 (0)11 2447118
    Email :chairman@spc.lk

  • Description :
  • y Subsequent renewal certificates where applicable or a copy certified by an Attorney at law, of aforesaid document
  • Documents :
  •  Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN
KazakhTenders Features

KazakhTenders Features

Fresh and verified Tenders from Kazakh. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • Accurate Tender Information
  • New Tenders Every Day
  • Consultants for RFI/RFP/RFQ
  • Search, sort, and filter Tenders
  • Customer Support
  • Publish your Tenders
  • Consulting Services
  • Export data to Excel or CRM

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ZimbabweTenders !!
Email Id is already exist !!
Invalid Captcha !

Get FREE SAMPLE TENDERS from Kazakh in your email inbox.

  Chat with us